Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03426280 · ClinicalTrials.gov registry record · NA
Activity Therapy After Kidney Transplant
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03426280: Clinical Trial NA study, sponsored by Stanford University.
NCT03426280 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03426280, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
To combat post-transplant weight gain, we seek to expand Stanford Kidney Transplant's multidisciplinary platform to include physical activity monitoring and coaching using the Apple Watch.
Interventions
- DEVICE Apple Watch Series 1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03426280
The ClinicalTrials.gov registry entry for NCT03426280 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Apple Watch Series 1 is the first listed.
NCT03426280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03426280 about?
NCT03426280 is a clinical study titled "Activity Therapy After Kidney Transplant". To combat post-transplant weight gain, we seek to expand Stanford Kidney Transplant's multidisciplinary platform to include physical activity monitoring and coaching using the Apple Watch.
What is the current status of trial NCT03426280?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2018-05-01. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT03426280?
The interventions under investigation include: Apple Watch Series 1 (DEVICE).
Who is sponsoring clinical trial NCT03426280?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.